Rwanda has confirmed 62 cases of the Marburg virus, a deadly virus with a fatality rate of 88%. Increasing recoveries and reduced infections signal improvement.
Health Minister Dr. Sabin Nsanzimana announced a positive trend in Marburg response, citing a reduction in new infections by over 50% for three consecutive weeks.
Currently, there are no licensed vaccines for Marburg virus, but clinical trials and proactive measures, including vaccine distribution to high-risk groups, are underway.
New U.S. screening measures will affect travelers from Rwanda, requiring direct flights into JFK for those arriving within 21 days of potential exposure.
Collection
[
|
...
]